Abstract Objective To investigate PHEX gene mutations in 2 patients with X-linked hypophosphatemic rickets (XLH) and their families and to clarify the genetic etiology. Methods A retrospective analysis was performed for the clinical data of two patients with XLH. High-throughput sequencing was used to detect the PHEX gene, a pathogenic gene of XLH. PCR-Sanger sequencing was used to verify the distribution of mutations in families. Results Both patients had novel mutations in the PHEX gene; one patient had a frameshift mutation, c.931dupC, which caused early termination of translation and produced the truncated protein p.Gln311Profs*13; the other patient had a splice site mutation, IVS14+1G > A, which caused the skipping of exon 15 and produced an incomplete amino acid chain. Their parents had normal gene phenotypes. Conclusions c.931dupC and IVS14+1G > A are two novel mutations of the PHEX gene and might be the new pathogenic mutations of XLH.
RAN Qing,XIONG Feng,ZHU Min et al. Novel PHEX gene mutations in patients with X-linked hypophosphatemic rickets: an analysis of 2 cases[J]. CJCP, 2017, 19(5): 534-538.
RAN Qing,XIONG Feng,ZHU Min et al. Novel PHEX gene mutations in patients with X-linked hypophosphatemic rickets: an analysis of 2 cases[J]. CJCP, 2017, 19(5): 534-538.
Francis F, Strom TM, Hennig S, et al. Genomic organization of the human PEX gene mutated in X-linked dominant hypophosphatemic rickets[J]. Genome Res, 1997, 7(6):573-585.
[2]
Bowe AE, Finnegan R, Jan de Beur SM, et al. FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate[J]. Biochem Biophys Res Commun, 2001, 284(4):977-981.
[3]
Xia WB, Jiang Y, Li M, et al. Levels and dynamic changes of serum fibroblast growth factor 23 in hypophosphatemic rickets/osteomalacia[J]. Chin Med J(Eng1), 2010, 123(9):1158-1162.
[4]
Liu S, Zhou J, Tang W, et al. Pathogenic role of Fgf23 in Hyp mice[J]. Am J Physiol Endocrinol Metab, 2006, 291(1):E38-E49.
[5]
Thakker RV, O'Riordan JL. Inherited forms of rickets and osteomalacia[J]. Baillieres Clin Endocrinol Metab, 1988, 2(1):157-191.
[6]
Clausmeyer S, Hesse V, Clemens PC, et al. Mutational analysis of the PHEX gene:novel point mutations and detection of large deletions by MLPA in patients with X-linked hypophosphatemic rickets[J]. Calcif Tissue Int, 2009, 85(3):211-220.
[7]
Whyte MP, Schranck FW, Armamento-Villareal R. X-linked hypophosphatemia:a search for gender, race, anticipation,or parent of origin effects on disease expression in children[J]. J Clin Endocrinol Metab, 1996, 81(11):4075-4080.
[8]
Beck-Nielsen SS, Brixen K, Gram J, et al. Mutational analysis of PHEX, FGF23, DMP1, SLC34a3 and CLCN5 in patients with hypophosphatemic rickets[J]. J Hum Genet, 2012, 57(7):453-458.
Yuan L, Wu S, Xu H, et al. Identification of a novel PHEX mutation in a Chinese family with X-linked hypophosphatemic rickets using exome sequencing[J]. Biol Chem, 2015, 396(1):27-33.
[14]
Yue H, Yu JB, He JW, et al. Identification of two novel mutations in the PHEX gene in Chinese patients with hypophosphatemic rickets/osteomalacia[J]. PLoS One, 2013, 9(5):e97830.
[15]
Holm IA, Nelson AE, Robinson BG, et al. Mutational analysis and genotype-phenotype correlation of the PHEX gene in X-linked hypophosphatemic rickets[J]. J Clin Endocrinol Metab, 2001, 86(8):3889-3899.
[16]
Kang QL, Xu J, Zhang Z, et al. Three novel PHEX gene mutations in four Chinese families with X-linked dominant hypophosphatemic rickets[J]. Biochem Biophys Res Commun, 2012, 423(4):793-798.
[17]
Zhu X, Li M, Pan H, et al. Analysis of the parental origin of de novo MECP2 mutations and X chromosome inactivation in 24 sporadic patients with Rett syndrome in China[J]. J Child Neurol, 2010, 25(7):842-848.
[18]
Gaucher C, Walrant-Debray O, Nguyen TM, et al. PHEX analysis in 118 pedigrees reveals new genetic clues in hypophosphatemic rickets[J]. Hum Genet, 2009, 125(4):401-411.
[19]
Filisetti D, Ostermann G, von Bredow M,et al. Non-random distribution of mutations in the PHEX gene, and under-detected missense mutations at non-conserved residues[J]. Eur J Hum Genet, 1999, 7(5):615-619.
[20]
Holm IA, Huang X, Kunkel LM, et al. Mutational analysis of the PHEX gene in patients with X-linked hypophosphatemic rickets[J]. Am J Hum Genet, 1997, 60(4):790-797.
[21]
Sato K, Tajima T, Nakae J, et al. Three novel PHEX gene mutations in Japanese patients with X-linked hypophosphatemic rickets[J]. Pediatr Res, 2000, 48(4):536-540.
[22]
Rowe PS, Oudet CL, Francis F, et al. Distribution of mutations in the PEX gene in families with X-linked hypophosphatemic rickets (HYP)[J]. Hum Mol Genet, 1997, 6(4):539-549.
[23]
Raeder H, Shaw N, Netelenbos C, et al. A case of X-linked hypophosphatemic rickets:complications and the therapeutic use of cinicalcet[J]. Eur J Endocrinol, 2008, 159(Suppl 1):S101-S105.
